Previous 10 | Next 10 |
SAN FRANCISCO and DUBLIN , May 6, 2019 /PRNewswire/ -- Medicines360, a nonprofit women's health pharmaceutical company with a mission of expanding access to quality medicines, and Allergan plc (NYSE: AGN), a leading global pharmaceutical company, presented new six-year data from Medicin...
DUBLIN , May 3, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the second quarter of 2019. The dividend will be paid on June 14, 2019 to shareholders of record at the close of ...
DUBLIN , May 3, 2019 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company with a heritage of more than 70 years in eye care, will present new data for its investigational implant, Bimatoprost SR, and a late-breaking analysis on its subconjunctival gelati...
DUBLIN , May 2, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the company will share 29 presentations at the 71 st Annual American Academy of Neurology (AAN) Meeting, including 10 oral podium presentations and 14 poster presentations highlighting the company's s...
DUBLIN , May 1, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced the voting results, representing 85.9 percent of shares eligible to be voted, from its Annual General Meeting of Shareholders held on May 1, 2019 in Dublin, Ireland . Shareholders elected all of the 11 n...
Krystal Biotech (KRYS) - The company announced presentations of clinical data for KB103 to treat DEB (dystrophic epidermolysis bullosa) and preclinical data on KB105 for the treatment of autosomal recessive congenital ichthyosis (ARCI) and KB104 for the treatment of Netherton syndrome at t...
DUBLIN, Ireland and CAMBRIDGE, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, announced initial data from the ongoing natural history study to evaluate p...
Noteworthy events during the week of April 28 - May 4 for healthcare investors. More news on: Catalyst Biosciences, Inc., Aldeyra Therapeutics, Inc., BioTime, Inc., Healthcare stocks news, , Read more ...
The European Medicines Agency's advisory group CHMP has issued a positive opinion recommending approval for Evolus' ( EOLS +2.1% ) Nuceiva (prabotulinumtoxinA-xvfs) for the temporary improvement of moderate-to-severe frown lines in adults below the age of 65. More news on: Evolus, Inc....
DUBLIN , April 25, 2019 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company with a more than 70-year heritage in eye care, will present new data at the Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO) to be held in Vanc...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET About to begin a phase 2b/3 multinational study of Ifenprodil Algernon Pharmaceuticals is a drug repurposing company. They're a phase 2 clinical stage company advancing a drug called Ifenprodil for idiopathic pulmonary fibrosis, but also as a potential thera...
2024-03-27 17:08:02 ET A stroke can be a devastating and debilitating event for an individual and their family, and a major burden on the health care system. Over 15 million people suffer strokes every year, and 85% of those have some form of disability as a result. Stroke-related cos...
2024-03-27 17:08:02 ET Stocks to Invest in: Healthcare Focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease Algernon is a drug re-purposing company that investigates safe, already approved drugs, inclu...